Cardiff Oncology Inc. (CRDF) at a glance

Cardiff Oncology Inc. (CRDF) is a micro-cap Healthcare company. It trades at $1, with a 0% profit margin and revenue decline of 62.4%. It does not pay a dividend. Vestovix scores it 36/100 overall. Its strongest dimension is Safety (52/100) and its weakest is Growth (11/100). It carries above-market volatility, so expect larger swings.

Price

$1.00

Market cap

$105.3M

P/E ratio

n/a

Dividend yield

None

Beta

1.38

52-week range

$0.76 to $3.31